Lotus Health Group Company (SHA:600186)
China
· Delayed Price · Currency is CNY 6.34
+0.12 (1.93%)
Jun 6, 2025, 3:00 PM CST
SHA:600186 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,862 | 2,644 | 2,099 | 1,687 | 1,810 | 1,643 | Upgrade
|
| Other Revenue | 2.39 | 2.39 | 2.07 | 4.02 | 5.23 | 11.82 | Upgrade
|
| Revenue | 2,864 | 2,646 | 2,101 | 1,691 | 1,815 | 1,655 | Upgrade
|
| Revenue Growth (YoY) | 28.94% | 25.98% | 24.23% | -6.83% | 9.69% | -2.81% | Upgrade
|
| Cost of Revenue | 2,092 | 1,977 | 1,741 | 1,454 | 1,592 | 1,366 | Upgrade
|
| Gross Profit | 771.78 | 669.42 | 359.71 | 237.42 | 223 | 288.96 | Upgrade
|
| Selling, General & Admin | 313.92 | 299.31 | 180.87 | 131.72 | 128.47 | 150.91 | Upgrade
|
| Research & Development | 44.52 | 40.59 | 28.73 | 21.56 | 22.07 | 17.72 | Upgrade
|
| Other Operating Expenses | 16.37 | 15.47 | 9.83 | 10.2 | 9.63 | 8.65 | Upgrade
|
| Operating Expenses | 378.22 | 358.78 | 225.24 | 167 | 157.4 | 175.78 | Upgrade
|
| Operating Income | 393.56 | 310.64 | 134.47 | 70.41 | 65.6 | 113.17 | Upgrade
|
| Interest Expense | -39.13 | -31.86 | -0.56 | -5.09 | -19.43 | -21.8 | Upgrade
|
| Interest & Investment Income | 16.93 | 18.69 | 21.05 | 16.72 | 11.46 | 5.79 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.96 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 4.42 | 4.42 | 1.5 | 4.68 | -1.33 | -2.41 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.64 | -3.43 | -1.62 | -4.07 | 4.08 | 2.08 | Upgrade
|
| EBT Excluding Unusual Items | 370.14 | 298.46 | 154.84 | 81.7 | 60.38 | 96.84 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.18 | -1.04 | Upgrade
|
| Gain (Loss) on Sale of Investments | -7.84 | -9.02 | - | - | -0.01 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.57 | -0.49 | - | - | -3 | 0.05 | Upgrade
|
| Asset Writedown | -11.26 | -11.26 | -1.5 | -0.96 | -3.29 | - | Upgrade
|
| Other Unusual Items | -0.02 | 0.12 | 17.45 | -20.35 | -0.2 | 8.23 | Upgrade
|
| Pretax Income | 350.45 | 277.81 | 170.8 | 60.39 | 53.7 | 104.08 | Upgrade
|
| Income Tax Expense | 94.36 | 78.27 | 40.12 | 13.39 | 10.77 | 27.14 | Upgrade
|
| Earnings From Continuing Operations | 256.09 | 199.55 | 130.68 | 47 | 42.93 | 76.94 | Upgrade
|
| Minority Interest in Earnings | -1.73 | 3.04 | -0.75 | -0.81 | 1.43 | -2.66 | Upgrade
|
| Net Income | 254.36 | 202.58 | 129.93 | 46.19 | 44.36 | 74.29 | Upgrade
|
| Net Income to Common | 254.36 | 202.58 | 129.93 | 46.19 | 44.36 | 74.29 | Upgrade
|
| Net Income Growth | 60.82% | 55.92% | 181.26% | 4.13% | -40.28% | 7.30% | Upgrade
|
| Shares Outstanding (Basic) | 1,653 | 1,688 | 1,856 | 1,540 | 1,479 | 1,486 | Upgrade
|
| Shares Outstanding (Diluted) | 1,653 | 1,688 | 1,856 | 1,540 | 1,479 | 1,486 | Upgrade
|
| Shares Change (YoY) | -10.97% | -9.05% | 20.54% | 4.13% | -0.46% | 7.30% | Upgrade
|
| EPS (Basic) | 0.15 | 0.12 | 0.07 | 0.03 | 0.03 | 0.05 | Upgrade
|
| EPS (Diluted) | 0.15 | 0.12 | 0.07 | 0.03 | 0.03 | 0.05 | Upgrade
|
| EPS Growth | 80.65% | 71.43% | 133.33% | - | -40.00% | - | Upgrade
|
| Free Cash Flow | -288.97 | 8.9 | -36.13 | 13.4 | -31.46 | -884.41 | Upgrade
|
| Free Cash Flow Per Share | -0.17 | 0.01 | -0.02 | 0.01 | -0.02 | -0.59 | Upgrade
|
| Gross Margin | 26.95% | 25.30% | 17.12% | 14.04% | 12.29% | 17.46% | Upgrade
|
| Operating Margin | 13.74% | 11.74% | 6.40% | 4.16% | 3.61% | 6.84% | Upgrade
|
| Profit Margin | 8.88% | 7.66% | 6.19% | 2.73% | 2.44% | 4.49% | Upgrade
|
| Free Cash Flow Margin | -10.09% | 0.34% | -1.72% | 0.79% | -1.73% | -53.45% | Upgrade
|
| EBITDA | 472.4 | 377.13 | 151.56 | 87.91 | 76.94 | 124.59 | Upgrade
|
| EBITDA Margin | 16.49% | 14.25% | 7.22% | 5.20% | 4.24% | 7.53% | Upgrade
|
| D&A For EBITDA | 78.83 | 66.48 | 17.09 | 17.49 | 11.34 | 11.42 | Upgrade
|
| EBIT | 393.56 | 310.64 | 134.47 | 70.41 | 65.6 | 113.17 | Upgrade
|
| EBIT Margin | 13.74% | 11.74% | 6.40% | 4.16% | 3.61% | 6.84% | Upgrade
|
| Effective Tax Rate | 26.92% | 28.17% | 23.49% | 22.17% | 20.05% | 26.08% | Upgrade
|
| Revenue as Reported | 2,864 | 2,646 | 2,101 | 1,691 | 1,815 | 1,655 | Upgrade
|
| Advertising Expenses | - | 3.11 | 4.42 | 0.77 | 1.27 | 0.9 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.